Lisa Cooper, Ph.D., has 18 years of diverse Regulatory Affairs experience in early and late-stage development and post-approval activities, of which approximately 10 years have been focused on oncology drugs and biologics. As a regulatory leader, her experience includes developing global strategic regulatory development plans, various regulatory filings, labeling, and advertising and promotion review. Her most recent notable achievement was as regulatory lead during the review, approval, and launch of LONSURF while at Taiho Oncology. Dr. Cooper has a Master of Science degree in Biology from Fairleigh Dickinson University and a Doctor of Philosophy degree in Corporate Leadership from Alvernia University.
Dr. Lisa Cooper
